Key result
MAVS cleavability strongly determines coxsackievirus B3 outcomes and is altered by a common human polymorphism.
Why the study?
Complete kinetic models are pervasive in chemistry but lacking in biological systems.
Complete kinetic modeling of coxsackievirus B3 reveals how host-cell feedback mechanisms, such as MAVS polymorphism and interferon response, regulate viral infectivity.
Delivers first complete CVB3 kinetic model; leaves open validation and extension to other viruses or antiviral testing.
Complete kinetic models are pervasive in chemistry but lacking in biological systems. We encoded the complete kinetics of infection for coxsackievirus B3 (CVB3), a compact and fast-acting RNA virus. The model consists of separable, detailed modules describing viral binding-delivery, translation-replication, and encapsidation. Specific module activities are dampened by the type I interferon response to viral double-stranded RNAs (dsRNAs), which is itself disrupted by viral proteinases. The experimentally validated kinetics uncovered that cleavability of the dsRNA transducer mitochondrial antiviral signaling protein (MAVS) becomes a stronger determinant of viral outcomes when cells receive supplemental interferon after infection. Cleavability is naturally altered in humans by a common MAVS polymorphism, which removes a proteinase-targeted site but paradoxically elevates CVB3 infectivity. These observations are reconciled with a simple nonlinear model of MAVS regulation. Modeling complete kinetics is an attainable goal for small, rapidly infecting viruses and perhaps viral pathogens more broadly. A record of this paper's transparent peer review process is included in the Supplemental information.
No takes yet. Share an insight, caveat, or question.
Lopacinski et al. (2021) studied Coxsackievirus B3 (CVB3) infection. Complete kinetic modeling of viral infection was evaluated on Viral outcomes and MAVS cleavability. Complete kinetic modeling of coxsackievirus B3 revealed that cleavability of the dsRNA transducer MAVS is a strong determinant of viral outcomes, altered by a common human polymorphism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: